These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27957722)

  • 1. Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft.
    Ukon N; Zhao S; Yu W; Shimizu Y; Nishijima KI; Kubo N; Kitagawa Y; Tamaki N; Higashikawa K; Yasui H; Kuge Y
    EJNMMI Res; 2016 Dec; 6(1):90. PubMed ID: 27957722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model.
    Murakami M; Zhao S; Zhao Y; Yu W; Fatema CN; Nishijima KI; Yamasaki M; Takiguchi M; Tamaki N; Kuge Y
    Oncol Lett; 2013 Sep; 6(3):667-672. PubMed ID: 24137387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment.
    Lee HJ; Oh SJ; Lee EJ; Chung JH; Kim Y; Ryu JS; Kim SY; Lee SJ; Moon DH; Kim TW
    Cancer Chemother Pharmacol; 2015 May; 75(5):1005-13. PubMed ID: 25776904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
    Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
    Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.
    Mason NS; Lopresti BJ; Ruszkiewicz J; Dong X; Joyce S; Leef G; Sen M; Wahed AS; Mathis CA; Grandis JR; Thomas SM
    Am J Nucl Med Mol Imaging; 2013; 3(1):16-31. PubMed ID: 23342298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT).
    Molthoff CF; Klabbers BM; Berkhof J; Felten JT; van Gelder M; Windhorst AD; Slotman BJ; Lammertsma AA
    Mol Imaging Biol; 2007; 9(6):340-7. PubMed ID: 17643202
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Grkovski M; Emmas SA; Carlin SD
    J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.
    Wagner M; Seitz U; Buck A; Neumaier B; Schultheiss S; Bangerter M; Bommer M; Leithäuser F; Wawra E; Munzert G; Reske SN
    Cancer Res; 2003 May; 63(10):2681-7. PubMed ID: 12750297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in tumor oxygen state after sorafenib therapy evaluated by
    Yu W; Zhao S; Zhao Y; Fatema CN; Murakami M; Nishijima KI; Kitagawa Y; Tamaki N; Kuge Y
    Oncol Lett; 2017 Aug; 14(2):2341-2346. PubMed ID: 28781672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Long of a Dynamic 3'-Deoxy-3'-[
    Zhang J; Liu X; Knopp MI; Ramaswamy B; Knopp MV
    Mol Imaging Biol; 2019 Apr; 21(2):382-390. PubMed ID: 29987617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial Concordance of Tumor Proliferation and Accelerated Repopulation from Pathologic Images to 3'-[
    Li C; Zhang X; Pang L; Huang Y; Gao Y; Sun X; Yu J; Meng X
    Mol Imaging Biol; 2019 Aug; 21(4):713-721. PubMed ID: 30406513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy.
    Katz SI; Zhou L; Ferrara TA; Wang W; Mayes PA; Smith CD; El-Deiry WS
    Int J Oncol; 2011 Jul; 39(1):91-100. PubMed ID: 21537838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
    Li Z; Herrmann K; Pirsig S; Philipp-Abbrederis K; Henninger M; Aichler M; Feuchtinger A; Walch A; Beer AJ; Ringshausen I; Pomykala KL; Scheidhauer K; Schwaiger M; Keller U; Buck AK
    Am J Nucl Med Mol Imaging; 2013; 4(1):70-9. PubMed ID: 24380047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
    Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA
    J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.
    Zhang CC; Yan Z; Li W; Kuszpit K; Painter CL; Zhang Q; Lappin PB; Nichols T; Lira ME; Affolter T; Fahey NR; Cullinane C; Spilker M; Zasadny K; O'Brien P; Buckman D; Wong A; Christensen JG
    Clin Cancer Res; 2012 Mar; 18(5):1303-12. PubMed ID: 22170262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic
    Scarpelli M; Simoncic U; Perlman S; Liu G; Jeraj R
    Phys Med Biol; 2018 Jul; 63(15):155008. PubMed ID: 29978839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.